4[2]Faro S. vulvovaginal candidiasis. In Faro S ed. Vaginitis:Differential diagnosis and Management. Parthenon Publishing,2004.45-65.
5[3]Bauters TG, Dhont MA, Temmerman MIL. Prevalence of vulvovaginal candidiasis and susceptibility to fluconzole in women. Am J Obstet Gynecol, 2002,187:569-574.
6[4]Leon de EM, Jacober SJ, Sobel JD, et al. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infectious Diseases,2002,2:1-6.
7[8]Corsello S, Spinillo A, Osnengo G, et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol, 2003,110:66-72.
9[13]Holland J,Young ML, Lee O, et al. Vulvovaginal carrage of yeasts other than Candida albicans. Sex Transm Infect,2003,79:249-250.
10[14]Sobel JD, Zervos M, Reed BD, et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated candida vaginitis:Clinical implications. Antimicrob Agents Chemother,2003,47:34-38.
